for people with chronic liver disease and hepatic encephalopathy (poor brain functioning) Cirrhosis is a chronic disorder of the liver. ... L-ornithine L-aspartate lowers blood ammonia levels and so may have beneficial effects in people with hepatic encephalopathy or help stop them developing it.
Purity
95%
Appearance
Colourless crystals
Melting Point
204C
Molecular Weight
133.11 g/mol Grams (g)
Shelf Life
6 Months
Physical Form
Powder
Molecular Formula
C4H7NO4
Density
1.7 g/cm Gram per millilitre (g/mL)
Product Description
L-ornithine-L-aspartate (LOLA) is a stable salt of two natural nonessential L-amino acids: ornithine and aspartic acid. It is formulated and marketed in low and high doses. Low doses are used as a food supplement and high doses (above 5 g) as a medicinal product to lower blood ammonia concentration and to eliminate symptoms of hepatic encephalopathy associated with liver cirrhosis. The aim of this review is to present physiological roles of L-ornithine and L-aspartate in the human body, to assess conditions under which these amino acids could be deficient, to analyze consequences of these deficiencies